Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Chinese Journal of Cardiology ; (12): 108-110, 2013.
Artigo em Chinês | WPRIM (Pacífico Ocidental) | ID: wpr-292017

RESUMO

<p><b>OBJECTIVE</b>To develop a new technique of bilateral angiography in a single radial access (BASiRalA) which can reduce a puncture site.</p><p><b>METHODS</b>From March 2011 to February 2012, 13 cases of coronary heart disease patients with chronic total occlusion (CTO) were treated (6 CTOs in right coronary artery and 7 in left anterior descending artery). All patients underwent percutaneous coronary intervention (PCI) via the right radial artery access and 6 F guiding catheters were delivered to the diseased artery. Once the wires crossed the CTO lesions and were uncertain if the wires were in true lumen or not, BASiRalA was performed. The Finecross microcatheters were advanced out of the 6 F guiding catheter, then withdraw 6F guiding catheter to the opening of diseased artery, the soft wires were manipulated into the middle portion of opposite coronary artery. After that, the microcatheters were advanced to this segment or the branches relative to the collateral vessels connected with CTOs. After pulling out the wires, microcatheter injections can be performed for contralateral angiography. BASiRalA related complications were observed after the procedure.</p><p><b>RESULTS</b>BASiRalA technique was applied to 13 CTOs and 10 procedures succeeded (76.92%). BASiRalA failed in 3 cases and the wires and microcatheters could not be advanced to the opposite coronary arteries within 20 minutes. Alternatively, contralateral angiography via femoral arteries was performed in these 3 patients. The average time of BASiRalA technique was 7 (5 - 13) minutes and the shortest time of wires crossing to the opposite coronary artery was 5 seconds. There was no procedure induced complication during procedure or post procedure.</p><p><b>CONCLUSION</b>BASiRalA technique is feasible in treating CTO patients by PCI.</p>


Assuntos
Idoso , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Angioplastia Coronária com Balão , Cateterismo Cardíaco , Métodos , Angiografia Coronária , Métodos , Oclusão Coronária , Terapêutica , Artéria Radial , Estudos Retrospectivos
2.
Artigo em Inglês | WPRIM (Pacífico Ocidental) | ID: wpr-314065

RESUMO

<p><b>OBJECTIVE</b>To evaluate the therapeutic effects of Quyu Xiaoban Capsule (QYXBC) on endothelial dependent vascular relaxation (EDVR) function in patients with atherosclerosis (AS) with ultrasonic technique.</p><p><b>METHODS</b>Tested were the endothelial function and blood lipids of 42 patients with AS in the treated group and 30 healthy volunteers in the control group. And re-examination of these parameters was carried out on the AS patients after they had been treated with QYXBC for 10 months.</p><p><b>RESULTS</b>Before treatment, the reactive hyperemia induced changes in artery diameter in the treated group was significantly lower than that in the control group (P < 0.01), while insignificant difference was found between the two groups in response to nitroglycerin. In the treated group after treatment, with D%-R improved significantly (P < 0.01), total cholesterol (TC), triglyceride (TG) and low-density lipoprotein cholesterol (LDL-C) decreased by 16.3%, 5.6%, 10.2% respectively and high-density lipoprotein cholesterol (HDL-C) increased by 7.5%. EDVR was correlated negatively with the serum TC, LDL-C concentrations and the baseline brachial diameter (D(0)) (r = -0.41, -0.66, -0.59, respectively, all P < 0.01), but correlated positively with HDL-C (r = 0.62, P < 0.05). The ameliorative extent of EDVR was correlated positively to the decreased magnitude of TC and LDL-C concentrations (r = 0.67, 0.59, both P < 0.01).</p><p><b>CONCLUSION</b>QYXBC can lower the level of blood lipids and improve significantly EDVR function.</p>


Assuntos
Adulto , Idoso , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Artéria Braquial , Fisiologia , Doenças das Artérias Carótidas , Diagnóstico por Imagem , Tratamento Farmacológico , HDL-Colesterol , Sangue , LDL-Colesterol , Sangue , Medicamentos de Ervas Chinesas , Endotélio Vascular , Fisiologia , Fitoterapia , Ultrassonografia , Vasodilatação
3.
Artigo em Chinês | WPRIM (Pacífico Ocidental) | ID: wpr-234840

RESUMO

<p><b>OBJECTIVE</b>To study the effect of Quyu Xiaoban capsule (QXC) on regression and stabilization of atherosclerotic plaque with high-frequency ultrasound technique.</p><p><b>METHODS</b>Eighty patients with atherosclerosis (AS) were randomly divided into the treated group and the control group, level of blood lipids was measured, and intima-media thickness (IMT) and corrected value of image average echo intensity (AIIc%) were determined by ultrasound technique at the beginning of experiment and after being treated for six months.</p><p><b>RESULTS</b>The levels of total cholesterol (TC) and low density lipoprotein cholesterol (LDL-C) were significantly decreased in the treated group after treatment (68.12 +/- 5.54 vs 61.43 +/- 5.37, P<0.05). The AIIc% of fatty atherosclerotic plaque was significantly increased after treatment (68.12 +/- 5.54 vs 61.43 +/- 5.37), and the change rate of AIIc% in the treated group was significantly different to that in the control group (10.9 +/- 5.1% vs 2.5 +/- 5.5%, P < 0.05).</p><p><b>CONCLUSION</b>QXC can significantly lower the blood lipids level, delay the progress and enhance the stability of atherosclerotic plaque.</p>


Assuntos
Adulto , Idoso , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Aterosclerose , Diagnóstico por Imagem , Tratamento Farmacológico , Patologia , Colesterol , Sangue , LDL-Colesterol , Sangue , Doença da Artéria Coronariana , Diagnóstico por Imagem , Tratamento Farmacológico , Patologia , Medicamentos de Ervas Chinesas , Usos Terapêuticos , Fitoterapia , Ultrassonografia
4.
Artigo em Chinês | WPRIM (Pacífico Ocidental) | ID: wpr-314123

RESUMO

<p><b>OBJECTIVE</b>To investigate the effect of Quyu Xiaoban Capsule (QYXB) on the regressive treatment of atherosclerosis (AS) with acoustic densitometry (AD) technique.</p><p><b>METHODS</b>Eighty patients with AS were randomly divided into two groups, trial group was treated with QYXB and conventional medicine, and control group was treated with conventional medicine alone. Normal arterial wall and different types of atherosclerotic plaques were detected with AD technique before treatment and 10 months later.</p><p><b>RESULTS</b>The corrected averages in intimal echo intensity (AIIc%) were elevated in both groups but without significant difference, AIIc% of fatty plaques were increased in both groups and the value after treatment was significantly higher than that of pre-treatment in the trial group (68.12 +/- 5.54 vs 61.43 +/- 5.37, P < 0.05). The increment rate of AIIc% in trial group was significantly higher than that in control group (10.9 +/- 5.1% vs 2.5 +/- 5.5%, P < 0.05).</p><p><b>CONCLUSION</b>QYXB can stabilize the atherosclerotic plaque by increasing its acoustic density. Acoustic densitometry technique can differentiate the different histological plaques and monitor the histological changes of plaques during treatment.</p>


Assuntos
Adulto , Idoso , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Artérias , Diagnóstico por Imagem , Aterosclerose , Diagnóstico por Imagem , Tratamento Farmacológico , Cápsulas , Estenose das Carótidas , Diagnóstico por Imagem , Tratamento Farmacológico , Densitometria , Medicamentos de Ervas Chinesas , Farmacologia , Usos Terapêuticos , Artéria Femoral , Medicina Tradicional Chinesa , Ultrassonografia
5.
Microbiology ; (12)1992.
Artigo em Chinês | WPRIM (Pacífico Ocidental) | ID: wpr-683967

RESUMO

According to the requirements of ptobiotics, we have separated 13 strains of Lactobacillus from the content in gut of lactating piglet. Among them 3strains are L. acidophilus, one is L. casei, one is L. atenaforme and 8 strains are L. fermentum. They can resist 1.0% bile salt and the acidity of pH3.0, can inhibit pathogenic Escherichia coli and Staphylococcus aureus. They are safe and non-toxic to mice.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...